Journal articles
Steinman L; Lindsey JW; Alters S; Hodgkinson S, 1993, 'From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.', Immunology Series, 59, pp. 253 - 260
Smilek DE; Wraith DC; Hodgkinson S; Dwivedy S; Steinman L; McDevitt HO, 1991, 'A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis', Proceedings of the National Academy of Sciences of the United States of America, 88, pp. 9633 - 9637
Knox SJ; Levy R; Hodgkinson S; Bell R; Brown S; Wood GS; Hoppe R; Abel EA; Steinman L; Berger RG; Gaiser C; Young G; Bindl J; Hanham A; Reichert T, 1991, 'Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides', Blood, 77, pp. 20 - 30, http://dx.doi.org/10.1182/blood.v77.1.20.20
Hodgkinson SJ; Pollard JD; McLeod JG, 1990, 'Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy', Journal of Neurology Neurosurgery and Psychiatry, 53, pp. 327 - 330, http://dx.doi.org/10.1136/jnnp.53.4.327
Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L, 1989, 'Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins', Proceedings of the National Academy of Sciences of the United States of America, 86, pp. 9470 - 9474, http://dx.doi.org/10.1073/pnas.86.23.9470
Conference Papers
Haile DC; Diouf I; Ozakbas S; Horakova D; Havrdova EK; Patti F; Eichau S; Alroughani R; Lugaresi A; Tomassini V; Prat A; Girard M; Terzi M; Yamout B; Khoury SJ; Grammond P; Blanco Y; Shaygannejad V; Foschi M; Surcinelli A; Neri S; Weinstock-Guttman B; Prevost J; Amato MP; Barnett M; Gerlach O; John N; Kermode AG; Fabis-Pedrini M; Carroll WM; van der Walt A; Butzkueven H; van Pesch V; Soysal A; Gouider R; Mrabet S; Spitaleri D; Cartechini E; Maimone D; Ampapa R; Laureys G; Ramo-Tello C; Di Gregorio M; Lapointe E; Slee M; Karabudak R; Garber J; Altintas A; Hodgkinson S; Sanchez-Menoyo JL; Castillo-Triviño T; Habek M; Al-Asmi A; Al-Harbi T; Csepany T; Cárdenas-Robledo S; Taylor B; Foong YC; Willekens B; Shalaby N; Moore F; McGuigan C; Baghbanian SM; Massey J; Hardy TA; Ramanathan S; Gross-Paju K; Gray O; Decoo D; Shaw C; Simu M; Rozsa C; Stuart EA; Sharmin S; Roos I; Kalincik T, 2026, 'Causal effects of multiple sclerosis therapies in left-truncated registry data', in Multiple Sclerosis Journal, SAGE Publications, pp. 1052 - 1068, http://dx.doi.org/10.1177/13524585261459943
Wiendl H; Meuth S; Pardo G; Zamvil S; Boer I; Bhatt A; Wu M; Hu X; Jehl V; Sullivan R; Montalban X; Cohen J; Hodgkinson S, 2025, '3544 Long-term ofatumumab treatment over 6 years did not increase the risk of serious infections', BMJ, pp. a37.1 - a3a37, presented at Poster Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.99
Roos I; Sharmin S; Lechner-Scott J; Buzzard K; Skibina O; Walt AVD; Butzkueven H; Barnett M; Macdonell R; John N; Hodgkinson S; Slee M; McCombe P; Garber J; Kermode AG; Fabis-Pedrini MJ; Carroll WM; Taylor B; Vukusic S; Kalincik T, 2025, '3614 Preserving neurological function in people at high and low risk of aggressive multiple sclerosis', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A56.2 - A57, presented at ANZAN Annual Scientific Meeting 2025 Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.153
Goorkiz P; Qiao J; Hodgkinson SJ; Wardman D, 2025, '3652 Bilateral optic neuropathy secondary to golimumab: a case report and review', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A64.2 - A64, presented at ANZAN Annual Scientific Meeting 2025 Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.175
Lizak N; Sharmin S; Walt AVD; Butzkueven H; Lechner-Scott J; Buzzard K; Skibina O; Hodgkinson S; Slee M; John N; Roos I; Kalincik T, 2024, '3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis', in Young Investigators Session Abstracts, BMJ Publishing Group Ltd, pp. A2.1 - A2, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.3
Roos I; Sharmin S; Malpas C; Lechner-Scott J; Hodgkinson S; Walt AVD; Butzkueven H; Buzzard K; Skibina O; John N; Barnett M; Kalincik T, 2024, '3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis', BMJ, pp. a43.1 - a4a43, presented at Poster Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.120
Migocki M; Walt AVD; Butzkueven H; Spelman T; Kermode A; Fabis-Pedrini M; Carroll WM; Lechner-Scott J; John N; Barnett M; Hodgkinson S; McCombe P; Kalincik T; Macdonell R; Slee M; Schmitt B, 2024, '3149 Real-world Australian experience with Ofatumumab in the MSBase registry', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A45.3 - A46, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.127
Wiendl H; De Stefano N; Barkhof F; Montalban X; Achiron A; Derfuss T; Chan A; Hodgkinson S; Prat A; Leocani L; Schmierer K; Sellebjerg F; Vermersch P; Jin H; Jarvinen E; Chudecka A; Gardner L, 2023, 'Blood Biomarker Dynamics in Highly Active Relapsing Multiple Sclerosis Patients Treated With Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study (S16.006)', in Neurology, Wolters Kluwer, http://dx.doi.org/10.1212/wnl.0000000000202961
De Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalban X; Prat A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Smyk A; Gardner L, 2023, 'Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study (P6-3.018)', in Neurology, Wolters Kluwer, http://dx.doi.org/10.1212/wnl.0000000000202977
Nguyen TBT; Hanna I; Li M; Chung CWT; Hodgkinson S, 2023, '2694 Mitochondrial neurogastrointestinal encephalopathy (MNGIE): a tale of two sisters', in Poster Abstract, BMJ Publishing Group Ltd, pp. A35.3 - A36, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.96
Hardy T; Aouad P; Barnett M; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; McCombe P; Parratt J; Plummer C; Walt AVD; Martel K; Walker R, 2023, '2723 Secondary progressive multiple sclerosis patients in Australia treated with siponimod; novel real-world evidence from the MSGo digital support program', in Poster Abstract, BMJ Publishing Group Ltd, pp. A41.2 - A41, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.113
Sharma M; Hodgkinson SJ; Skinner CM; Murambiwa P; DO’Neill DT, 2023, '2751 Preference and cost of oral vs intravenous methylprednisone for treatment of acute MS relapses', in Poster Abstract, BMJ Publishing Group Ltd, pp. A47.1 - A47, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.129
Hardy T; Aouad P; Barnett M; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; McCombe P; Parratt J; Plummer C; Van der Walt A; Martel K; Walker R, 2023, 'Novel Real World Evidence from MSGo, a Digital Support Program for Secondary Progressive Multiple Sclerosis Patients in Australia using Siponimod', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. NP44 - NP46
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 5 - 6, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Sharmin S; Malpas C; Lechner-Scott J; Slee M; McCombe P; Vucic S; Butler E; Hodgkinson S; Barnett M; Skibina O; van der Walt A; Buzzard K; Shaw C; Kermode A; Taylor B; Shuey N; Macdonell R; Butzkueven H; Kalincik T, 2022, 'Confirmed disability progression as a marker of permanent disability in multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 8 - 8, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Sharmin S; Malpas C; Lechner-Scott J; Slee M; McCombe P; Vucic S; Butler E; Hodgkinson S; Barnett M; Skibina O; van der Walt A; Buzzard K; Shaw C; Kermode A; Taylor B; Shuey N; Macdonell R; Butzkueven H; Kalincik T, 2022, 'Confirmed disability progression as a marker of permanent disability in multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 8 - 8, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; van der Walt A; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2022, 'Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 6 - 7, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Zhong M; van der Walt A; Hodgkinson S; Kalincik T; Izquierdo G; Eichau S; Grand'Maison F; Lechner-Scott J; Buzzard K; Skibina O; Butler E; Prevost J; McCombe P; Van Pesch V; Oh J; Butzkueven H; Jokubaitis V, 2022, 'Time to relapse after switching to cladribine is predicted by relapse during the washout period', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 11 - 11, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Hardy T; Aouad P; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; Parratt J; Plummer C; Walt AVD; Walker R, 2022, '2258 Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia', BMJ, pp. a25.1 - a2a25, presented at Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.64
Hodgkinson S; Hauser SL; Edward E; Aungst A; Su W; Zielman R; Gupta AD; Hu X; Stoneman D; Robertson D; Cohen J; Kappos L, 2022, '2265 Long-term efficacy of ofatumumab in patients with relapsing multiple sclerosis', in Abstracts, BMJ Publishing Group Ltd, pp. A26.2 - A26, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.68
Vitkova M; Diouf I; Malpas C; Barnett M; Hodgkinson S; Butler E; Slee M; Taylor B; Butzkueven H; Lechner-Scott J; McCombe P; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, '2327 Latitude, UVR and multiple sclerosis severity', in Abstracts, BMJ Publishing Group Ltd, pp. A11.3 - A12, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.29
Maltby VE; Lea RA; Monif M; Fabis-Pedrini MJ; Buzzard K; Kalincik T; Kermode AG; Taylor B; Hodgkinson S; McCombe P; Osborne M; Butzkueven H; Barnett M; Lechner-Scott J, 2022, 'Cladribine: a multicentre, LOng-term efficacy and Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 26 - 26
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 5 - 6
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; van der Walt A; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2022, 'Disease reactivation after cessation of diseasemodifying therapy in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 6 - 7
Zhong M; van der Walt A; Hodgkinson S; Kalincik T; Izquierdo G; Eichau S; Grand'Maison F; Lechner-Scott J; Buzzard K; Skibina O; Butler E; Prevost J; McCombe P; Van Pesch V; Oh J; Butzkueven H; Jokubaitis V, 2022, 'Time to relapse after switching to cladribine is predicted by relapse during the washout period', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 11 - 11
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Variability of the response to immunotherapy among sub-groups of patients with multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 7 - 7
Yeh WZ; Widyastuti PA; Van der Walt A; Stankovich J; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sá MJ; McCombe P; Grammond P; Ampapa R; Grand’Maison F; Bergamaschi R; LA Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Gresle M; Uher T; Maimone D; Turkoglu R; Hupperts RM; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis VG; Registry M, 2021, '004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis', in BMJ Neurology Open, BMJ, pp. a2 - a2, presented at Oral abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.4
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; Walt AVD; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2021, '006 Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in Oral abstracts, BMJ Publishing Group Ltd, pp. A3.1 - A3, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.6
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; van der Walt A; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2021, '008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis', in BMJ Neurology Open, BMJ, pp. a4 - a4, presented at Oral abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.8
Butzkueven H; Spelman T; Kalincik T; Buzzard K; Van der Walt A; Lechner-Scott J; Hodgkinson S; Butler E; Macdonell R; Slee M; Group MS; Marcel B, 2021, '010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort', in BMJ Neurology Open, BMJ, pp. a4 - a5, presented at Oral abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.10
Yeh W; Widyastuti P; Van der Walt A; Stankovich J; Gresle M; Havrdova E; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis V, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of relapse during pregnancy', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 30 - 31, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Hodgkinson S; Kalincik T; Buzzard K; Skibina O; Eichau Madueno S; Izquierdo G; Van der Walt A; Grand-Maison F; Butler E; Prevost J; Mccombe P; Oh J; Macdonell R; Lechner-Scott J; Van Pesch V; Duquette P; Prat A; Girard M; Kermode A; Fabris J, 2020, 'Real-world experience with cladribine tablets in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 549 - 549, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101671&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
De Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalban X; Prat A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2020, 'A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY-MS Baseline Analysis (1487)', in Neurology, Wolters Kluwer, http://dx.doi.org/10.1212/wnl.94.15_supplement.1487
Butzkueven H; Spelman T; Patti F; Ozakbas S; Eichau S; Alroughani R; Terzi M; Boz C; Grand'Maison F; Grammond P; Kalincik T; Van Pesch V; Lechner-Scott J; Barnett M; Kuhle J; Hodgkinson S; Skibina O; Soysal A; Butler E; Slee M; Prevost J; Laureys G; Macdonell R; van Beek J; Craveiro L; Wormser D; Muros-Le Rouzic E, 2019, 'Real-world experience with Ocrelizumab in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 539 - 540, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019
Malpas CB; Roos I; Sharmin S; Butzkueven H; Kappos L; Patti F; Alroughani R; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Hodgkinson S; Grammond P; Lechner-Scott J; Kalincik T, 2019, 'Disease reactivation following fingolimod cessation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 330 - 331, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2019, 'Real-world experience with Cladribine in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 326 - 327, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hodgkinson S; Sharma M, 2019, 'Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering diseased modifying drugs (DMDs)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at 71st Annual Meeting of the American-Academy-of-Neurology (AAN), PA, Philadelphia, 04 May 2019 - 10 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000475965903372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand'Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2017, 'Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 596 - 597, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Kalincik T; Spelman T; Jokubaitis V; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Lugaresi A; Grammond P; Alroughani R; Lechner-Scott J; Prevost J; Terzi M; Grand'Maison F; Boz C; Trojano M; Van Wijmeersch B; Pucci E; Granella F; Turkoglu R; Sola P; Ferraro D; McCombe P; Solaro C; Van Pesch V; Ozakbas S; Slee M; Spitaleri D; Sanchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Vucic S; Butzkueven H, 2017, 'Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 325 - 327, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; Taylor B; Mac Gregor S; Oconnell AM; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Sheuy N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2017, 'MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 403 - 404, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kapos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2017, 'Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 356 - 357, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Jokubaitis VG; Havrdova E; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Nguyen A-L; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo C; Turkoglu R; McCombe P; Hupperts R; Bolanos RF; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Iuliano G; Solaro C; Olascoaga J; Shaw C; Madsen K; Naidoo K; Hyde R; Butzkueven H, 2017, 'Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 130 - 132, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Spelman T; Schulz M; Arora B; Chung E; Juneja P; Walker R; Verhaeghe S; Butzkueven H; Hodgkinson S; Lechner-Scott J; McCombe P; Slee M; Butler E; Barnett M; Skibina O; Vucic S; Macdonell R; Shuey N; Taylor B; Broadley S, 2017, 'Persistence to fingolimod compared with other disease modifying therapies in the Australian real-world setting using the MS base registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 631 - 631, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730204050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jokubaitis V; Ai-Lan N; Kalincik T; van der Walt A; Lechner-Scott J; Barnett M; McCombe P; Vucic S; Hodgkinson S; Slee M; Skibina O; Shaw C; Butzkueven H, 2017, 'Pregnancy incidence, therapy exposure and post-partum relapse risk: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP4 - NP4, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Firtko A; Thomas P; Hodgkinson S, 2017, 'Effect of Post-Acute Nurse Led Stroke Clinic (PASC) on readmissions rates for TIA/Stroke', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 10 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408220500026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Back to profile page
https://orcid.org/0000-0002-9029-6663